人们对使用大麻治疗癌症疼痛越来越感兴趣。本评论旨在在大麻政策长期种族化的背景下，以及持有少数种族身份的癌症患者在疼痛控制方面的差异的背景下，讨论有关使用大麻治疗癌症疼痛的证据。关于癌症患者和所有患者使用大麻的益处和危害的大量证据尚缺乏。尽管利用现有的癌症研究，但也很重要的是要说明大麻在医学、政治和社会历史中的深厚根源如何影响患者使用和医疗保健政策的更广泛背景。我们可以从阿片类药物风险缓解策略的种族差异中吸取教训，因此它们不会在用于癌症症状管理的大麻环境中复制。此外，作者在这里故意使用“大麻”一词，而不是“大麻”。：在 1900 年代初期，普通媒体和政府普遍使用“大麻”一词，而不是更常见的“大麻”来将毒品与毒品联系起来。反墨西哥偏见。© 2023 The Authors. Cancer 由 Wiley periodicals LLC 代表美国癌症协会出版。

There is growing interest in cannabis use for cancer pain. This commentary aims to discuss the evidence surrounding cannabis use for cancer pain in the context of the long-racialized landscape of cannabis policies and the disparity in pain control among cancer patients holding minoritized racial identities. Much evidence surrounding both the benefits and harms of cannabis use in cancer patients, and all patients in general, is lacking. Although drawing on the research in cancer that is available, it is also important to illustrate the broader context about how cannabis' deep roots in medical, political, and social history impact patient use and health care policies. There are lessons we can learn from the racialized disparities in opioid risk mitigation strategies, so they are not replicated in the settings of cannabis for cancer symptom management. Additionally, the authors intentionally use the term "cannabis" here rather than "marijuana.: In the early 1900s, the lay press and government popularized the use of the word "marijuana" instead of the more common "cannabis" to tie the drug to anti-Mexican prejudice.© 2023 The Authors. Cancer published by Wiley Periodicals LLC on behalf of American Cancer Society.